Sansure Biotech Inc. (SHA:688289)
China
· Delayed Price · Currency is CNY 20.47
+0.32 (1.59%)
Jun 16, 2025, 11:29 AM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 11.57 billion as of June 13, 2025. Its market cap has increased by 1.17% in one year.
Market Cap
11.57B
Enterprise Value
8.00B
Revenue
1.54B
Ranking
n/a
PE Ratio
41.17
Stock Price
20.47
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 11.57B, a decrease of -75.08%. That is a compound annual growth rate of -25.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 11.57B | -11.01% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | 45.58B | -1.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 357.20B |
| Shenzhen Mindray Bio-Medical Electronics | 286.96B |
| WuXi AppTec | 196.82B |
| Sichuan Biokin Pharmaceutical | 130.53B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.53B |
| Aier Eye Hospital Group | 113.59B |
| Shanghai United Imaging Healthcare | 106.19B |
| Yunnan Baiyao Group Co.,Ltd | 100.81B |